Suppr超能文献

针对人布鲁氏菌病感染的 LAMP-PCR 靶向 bcsp-31 基因的诊断效用。

Diagnostic utility of LAMP PCR targeting bcsp-31 gene for human brucellosis infection.

机构信息

Research Center, Dr. G.M. Taori Central India Institute of Medical Sciences (CIIMS), 88/2, Bajaj Nagar, Nagpur, Maharashtra, India.

Deptartment of Biochemistry, North-Eastern Hill University (NEHU), Shillong, India.

出版信息

Indian J Med Microbiol. 2023 Jul-Aug;44:100354. doi: 10.1016/j.ijmmb.2023.01.012. Epub 2023 May 11.

Abstract

PURPOSE

Human brucellosis is a neglected zoonotic disease of significant public health concern. Molecular diagnosis of brucella remains challenging in low resource settings, due to the high infrastructure and cost involved. Loop-mediated isothermal amplification (LAMP) is a rapid point of care polymerase chain reaction (PCR) with the utility of on-field molecular diagnosis and offers a convenient alternative to conventional PCR. In the present study, we developed and evaluated the diagnostic utility of in house LAMP PCR targeting the Brucella genus-specific bcsp-31 gene in patients having febrile illness.

MATERIALS AND METHODS

The analytical sensitivity and specificity of bcsp-31 LAMP PCR was first evaluated using brucella (n ​= ​8) and non-brucella cultures (n ​= ​5), along with spiked clinical samples. The overall diagnostic utility of developed LAMP PCR was then further evaluated in 393 human samples suspected of brucellosis.

RESULTS

The developed LAMP PCR could detect as low as 8 ​fg of DNA by visual detection within 35min. We report sensitivity and specificity of the developed LAMP PCR as 90.91% and 99.37%.The accuracy of the developed test assay was found to be 98.60%. In clinical samples, LAMP gave positivity of 20% with the concordance of 89% with conventional PCR.

CONCLUSION

To conclude, a rapid, efficacious, sensitive LAMP PCR targeting the bcsp 31 gene was developed. The existing LAMP PCR can be used as a point of care screening test in various low resource endemic setting in lieu of conventional PCR for estimation of prevalence data, diagnosis and treatment of brucellosis.

摘要

目的

人类布鲁氏菌病是一种被忽视的动物源性传染病,对公共健康具有重要意义。由于涉及到高基础设施和成本,在资源匮乏的环境中,对布鲁氏菌进行分子诊断仍然具有挑战性。环介导等温扩增(LAMP)是一种快速的即时聚合酶链反应(PCR),具有现场分子诊断的实用价值,为传统 PCR 提供了一种便捷的替代方法。本研究中,我们针对布鲁氏菌属特异性 bcsp-31 基因开发并评估了现场使用的 LAMP-PCR 的诊断效用,该方法针对发热患者。

材料和方法

首先使用布鲁氏菌(n=8)和非布鲁氏菌培养物(n=5)以及加标临床样本评估 bcsp-31 LAMP-PCR 的分析灵敏度和特异性。然后,进一步在 393 例疑似布鲁氏菌病的人类样本中评估了开发的 LAMP-PCR 的总体诊断效用。

结果

通过 35 分钟内的目视检测,开发的 LAMP-PCR 可以检测到低至 8 fg 的 DNA。我们报告了开发的 LAMP-PCR 的灵敏度和特异性分别为 90.91%和 99.37%。开发测试的准确性被发现为 98.60%。在临床样本中,LAMP 的阳性率为 20%,与传统 PCR 的一致性为 89%。

结论

总之,针对 bcsp 31 基因开发了一种快速、有效、敏感的 LAMP-PCR。现有的 LAMP-PCR 可作为各种资源匮乏的流行地区的即时护理筛选测试,替代传统 PCR 用于估计患病率数据、诊断和治疗布鲁氏菌病。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验